MRI-derived myocardial extracellular volume fraction (ECV) is elevated in the presence of fibrosis, amyloid deposition, inflammation and edema. In patients with cardiac amyloidosis and prolonged T2 ...

Diabetic neuropathy refers to nerve damage that develops gradually and is caused by long-term high blood sugar levels. While there’s no cure, managing blood sugar levels can slow its progression ...

(AP Photo/Heather Khalifa) Jake Heinrichs prepares for his infusion treatment with an experimental anti-amyloid Alzheimer’s drug while at home in New York, on Wednesday, March 12, 2025. (AP ...

An illustration depicts cells in an Alzheimer’s-affected brain, with abnormal levels of beta amyloid protein clumping together to form plaques that collect between neurons and disrupt cell function.

Gantenerumab helps eliminate one of the neurological hallmarks of Alzheimer’s, called amyloid plaques. For some participants, gantenerumab reduced their risk of developing the disease by more ...

The kidneys become hard and small with buildup of amyloid. It is important for the nurse to assess the extent of kidney involvement in amyloidosis and the development of the nephrotic syndrome.

The agency cleared the drug, called Amvuttra, for people with a cardiac form of the rare disease transthyretin amyloidosis. Alnylam already ... is very high in the neuropathy form of ATTR. “You don’t ...

One year earlier, in June 2021, the US Food and Drug Administration had approved aducanumab, an antibody-targeting beta-amyloid, as a treatment for Alzheimer's, even though the data supporting its use ...

For the first time, scientists say, they have evidence that using a biologic drug to remove sticky beta amyloid plaques from the brains of people destined to develop Alzheimer’s dementia can ...

The findings suggest -- for the first time in a clinical trial -- that early treatment to remove amyloid plaques from the brain many years before symptoms arise can delay the onset of Alzheimer's ...

and Joanne Knight Distinguished Professor of Neurology at WashU Medicine, is the study director of an international clinical trial that finds an anti-amyloid drug can delay the onset of cognitive ...